Frontlight ResearchEarly access
Not yet recruitingNo phase
Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection
Key facts
- Who runs it
- Zhongda Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 208 people, planned
- Started
- Jun 2025
- Planned end
- Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Bismuth quadruple therapy
- Saccharomyces boulardii
- Record updated
- 10 June 2025
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Aged 18-70 years, regardless of gender
- Positive 13C/14C urea breath test result
- No previous history of H. pylori eradication treatment
- Agreement to participate in this study and signing of the informed consent form
Who cannot take part
- History of ≥ 1 instance of failed H. pylori eradication
- Severe liver, kidney, or cardiovascular diseases; malignancies; and alcoholism
- Allergies to the drugs used in this study or a history of penicillin allergy
- The inability to correctly express one's symptoms and wishes, such as inability due to mental illness or severe neurosis
- Use of antibiotics (including antibacterial traditional Chinese medicines), nonsteroidal anti-inflammatory drugs (NSAIDS), bismuth agents, H2 receptor antagonists (H2RAs), proton-pump inhibitors (PPIs), and potassium-competitive acid blockers (P-CAB) within 4 weeks before treatment
- Plans to conceive, pregnancy, or breastfeeding
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To assess the efficacy and safety of Saccharomyces boulardii combined with triple therapy containing minocycline in the initial eradication of Helicobacter pylori (H. pylori) infection
The 2 groups in the trial
- Control GroupExisting treatment, for comparison
Treatment: Bismuth quadruple therapy
- Experimental groupTreatment being tested
Treatment: Saccharomyces boulardii
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07012785, who can take part
- Record updated
- 10 June 2025